LOADING...
Log in and
comment
Username or Email
Password
Forgot password?
Or
Join and
publish
You're almost done! Define a user name and password.
Username
Email
Password
Senha
» Tip Us Hey you, we are hiring! Join us if you are an author, developer or designer!

Alphabet's Verily gets ECG approval for its Study Watch by FDA

22 January 2019 3

Verily from Alphabet, the parent company of Google introduced its health watch in 2017. It is particularly aimed at gathering insights on medical conditions like MS and Parkinson’s.

Now Verily has achieved the FDA clearance for its electrocardiogram (ECG) technology. This means the watch will offer various future indications and the agency has designated the watch as a Class II medical device. Verily while announcing this major milestone stated that its area of focus for Study Watch has been cardiovascular health because it has been killing the lives. According to the American Heart Association (AHA), most cardiovascular events are preventable so mobile health sector must enhance so to eradicate this major problem.

According to Engadget, doctors may prescribe the device to individuals as part of their clinical care while the research trials are going on.

The FDA-cleared Study Watch intends to record, store, transfer, and display single-channel ECG rhythms and is indicated for use by healthcare professionals, adult patients with known or suspected heart conditions

Verily writes,

“Receiving this clearance showcases our commitment to the high standards of the FDA for safety and effectiveness and will help us advance the application of Study Watch in various disease areas and future indications.”


3

Comments

Join our community » Alphabet's Verily gets ECG approval for its Study Watch by FDA
Android

Most affordable 4GB RAM smartphones | February 2019

Android

Top 5 best bezel-less smartphones | February 2019

Android

Top 5 Compact smartphones available for purchase in January 2019

Android

Best dual front camera smartphones | February 2019